The Drug Enforcement Administration is proposing to set more stringent limits on the amount of opioids the U.S. is allowed to produce, according to Drug Topics.
The agency is proposing to reduce the production amount of five opioids, including oxymorphone, fentanyl, hydrocodone, hydromorphone and oxycodone, which were subject to greater scrutiny after the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act was passed last year.
Combined with morphine, the proposal would lead to a 53 percent decrease in the allowable amount of these opioids since 2016, according to Drug Topics.
Read the full report here.
More articles on pharmacy:
Florida compounding facility recalls all human and animal drugs for lack of sterility
Despite 'Right-to-try' law, drugmakers still prefer FDA review, GAO finds